(111 days)
K03150
No
The description focuses on standard image processing, statistical analysis, and visualization tools, with no mention of AI or ML algorithms.
No
The device is described as post-processing software that provides additional information for diagnosis and streamlines workflow for radiologists. It does not directly treat or diagnose a disease.
Yes
The device aids radiologists in their diagnosis by providing mathematical and statistical information from medical images, helping them characterize lesions and streamline the diagnostic process.
Yes
The device is described as "post processing software designed to receive 3TP specific series and provide additional tools to analyze those 3TP series." It operates on data generated by another software (3TP Software algorithm) and provides analytical and visualization tools. There is no mention of any hardware component being part of the device itself.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for the diagnosis, treatment, or prevention of disease.
- Device Function: The description clearly states that the device is "post processing software designed to receive 3TP specific series and provide additional tools to analyze those 3TP series." These 3TP series are generated from dynamic MR data, which is an in vivo imaging technique, not an in vitro specimen analysis.
- Intended Use: The intended use focuses on analyzing and presenting data derived from MRI images to aid radiologists in diagnosis. This is consistent with medical image analysis software, not IVD testing.
- Lack of Specimen Handling: There is no mention of the device handling or analyzing any biological specimens.
Therefore, while this device is a medical device used in the diagnostic process, it falls under the category of medical image processing software rather than an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Workspace is intended for use in conjunction with 3TP's proprietary post processing pharmacokinetic analysis software (FDA 510(k) number: K03150) to provide additional mathematical and/or statistical information specific to a particular region within a 3TP color-coded image. The Workspace does not change the original 3TP Software algorithm or the image series produced by the 3TP The Workspace supports the analysis and presentation of datasets algorithm. generated by 3TP Software algorithm and incorporates the following functions: Pixel of Interest curve (POI), Region of Interest curve (ROI), Report Card, Volume Calculation, 3TP Histogram, and 3-D visualization of 3TP data series.
The POI and ROI curve functions provide contrast enhancement data for a specific pixel or region of interest within the MRI image series. Whereas the POI function measures signal intensity enhancement for a specific pixel, the ROI function averages the enhancement in signal intensity for a manually specified region (several pixels). In both cases, the Workspace presents a graph depicting the percent change in intensity through all time points.
The Report Card function classifies, counts and calculates the percentage of pixels of a given color and intensity in a single or in multiple slices for any manually specified region of interest. The Report Card offers the ability to evaluate a subset of the data originally generated by the 3TP algorithm in a numbers based, non-image presentation format. The Report Card assists the user by providing number based data of the contrast kinetics of a specified region identified by the radiologist in order to further aid in his diagnosis.
The Volume Calculation function allows the user to measure the volume of a region in multiple image slices specified by the radiologist.
The "3TP Histogram" is used to simultaneously display measurements of two physiological parameters found from a full pharmacokinetic analysis of the dynamic behavior of voxels in a chosen ROI. Each bin in the histogram shows the total number of voxels from the designated ROI with corresponding Permeability (PERM) and Extracellular Volume Fraction (EVF). Two solid lines on the histogram plot show the Blue/Green and Green/Red separations of the map: That is, voxels in the bins of red section are colored red on 3TP-color maps based on full analysis.
The Heterogeneity Analysis provides a standardized statistical analysis of the varrying populations of color hue and color intensity within a specified region or volume of interest. This function assists the radiologist in determining the degree of heterogeneity or homogeneity of a user specified region in terms of the color-coded pixels that are contained within. If the Full Analysis was performed, Heterogeneity Analysis may be performed also for Permeability and EVF of voxels within specified ROI.
The Workspace product serves as a workflow roadmap tool that organizes and guides the radiologist through the series of sequential tasks that must be performed in order to arrive at a diagnosis. The specific configuration of product features drives the Workspace's underlying workflow solution for lesion characterization and reporting. This inherent workflow regime integrates easily into the radiologist's existing departmental workflow and can be adapted to fit the needs of each user, thereby streamlining diagnosis.
The 3-D Visualization tool provides colored Maximum Intensity Projections (MIP) or other 3D visualization tools that are specific to the 3TP image datasets.
Product codes
LLZ
Device Description
3TP Workspace is intended to be used as post processing software designed to receive 3TP specific series and provide additional tools to analyze those 3TP series. 3TP itself, supports the evaluation of dynamic MR data gathered during the injection of a bolus of contrast media. The resulting time course information can be displayed in a variety of formats, including a parametric image overlaid onto source MR images.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
MRI image series
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
radiologist
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The 3TP Workspace will successfully complete integration testing and verification prior to beta validation and the software beta testing will be successfully completed validating the 3TP Workspace prior to market release.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
K03150
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the perimeter. Inside the circle is a stylized graphic of three human profiles facing to the right, stacked one above the other.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
SEP 1 4 2005
Mr. Michael M. Kochian Management Representative, Ouality Assurance and Regulatory Affairs 3TP Imaging Sciences 245 Main Street, Suite #620 WHITE PLAINS NY 10601
Re: K050862
Trade/Device Name: Workspace Regulation Number: 21 CFR §892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: June 22, 2005 Received: June 27, 2005
Dear Mr. Kochian:
This letter corrects our substantially equivalent letter of July 25, 2005.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing
1
Page 2 - Mr. Michael Kochian
(21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to continue marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:
| 21 CFR 876.xxxx | (Gastroenterology/Renal/Urology) | 240-276-0115 |
|---|---|---|
| 21 CFR 884.xxxx | (Obstetrics/Gynecology) | 240-276-0115 |
| 21 CFR 892.xxxx | (Radiology) | 240-276-0120 |
| .Other | 240-276-0100 |
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html
· Sincerely yours,
Nancy C. Brogdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
ATTACHMENT 7 Indications for Use Statement
510(k) Number (if known):__K با کا کا کا کا ک
Device Name: Workspace
Indications for Use:
The Workspace is intended for use in conjunction with 3TP's proprietary post processing pharmacokinetic analysis software (FDA 510(k) number: K03150) to provide additional mathematical and/or statistical information specific to a particular region within a 3TP color-coded image. The Workspace does not change the original 3TP Software algorithm or the image series produced by the 3TP The Workspace supports the analysis and presentation of datasets algorithm. generated by 3TP Software algorithm and incorporates the following functions: Pixel of Interest curve (POI), Region of Interest curve (ROI), Report Card, Volume Calculation, 3TP Histogram, and 3-D visualization of 3TP data series.
The POI and ROI curve functions provide contrast enhancement data for a specific pixel or region of interest within the MRI image series. Whereas the POI function measures signal intensity enhancement for a specific pixel, the ROI function averages the enhancement in signal intensity for a manually specified region (several pixels). In both cases, the Workspace presents a graph depicting the percent change in intensity through all time points.
The Report Card function classifies, counts and calculates the percentage of pixels of a given color and intensity in a single or in multiple slices for any manually specified region of interest. The Report Card offers the ability to evaluate a subset of the data originally generated by the 3TP algorithm in a numbers based, non-image presentation format. The Report Card assists the user by providing number based data of the contrast kinetics of a specified region identified by the radiologist in order to further aid in his diagnosis.
The Volume Calculation function allows the user to measure the volume of a region in multiple image slices specified by the radiologist.
The "3TP Histogram" is used to simultaneously display measurements of two physiological parameters found from a full pharmacokinetic analysis of the dynamic behavior of voxels in a chosen ROI. Each bin in the histogram shows the total number of voxels from the designated ROI with corresponding Permeability (PERM) and Extracellular Volume Fraction (EVF). Two solid lines on the histogram plot show the Blue/Green and Green/Red separations of the map: That is, voxels in the bins of red section are colored red on 3TP-color maps based on full analysis.
3
The Heterogeneity Analysis provides a standardized statistical analysis of the varving populations of color hue and color intensity within a specified region or volume of interest. This function assists the radiologist in determining the degree of heterogeneity or homogeneity of a user specified region in terms of the color-coded pixels that are contained within. If the Full Analysis was performed, Heterogeneity Analysis may be performed also for Permeability and EVF of voxels within specified ROI.
The Workspace product serves as a workflow roadmap tool that organizes and guides the radiologist through the series of sequential tasks that must be performed in order to arrive at a diagnosis. The specific configuration of product features drives the Workspace's underlying workflow solution for lesion characterization and reporting. This inherent workflow regime integrates easily into the radiologist's existing departmental workflow and can be adapted to fit the needs of each user, thereby streamlining diagnosis.
The 3-D Visualization tool provides colored Maximum Intensity Projections (MIP) or other 3D visualization tools that are specific to the 3TP image datasets.
(PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use _ L
OR
Over-The-Counter Use
(Per 21 C.F.R. 801.109)
(Optional Format 1-2-96)
Nancy C. Brogdon
Division Sign Off Division of Reproduct and Radiological Devic Number
4
ATTACHMENT 7
Summary of Information Respecting Safety And Effectiveness JUL 2 5 2005
This 510(K) summary of safety and effectiveness information is submitted in accordance with the requirements of 21 CFR Part 807.87(h).
| Contact: | Vincent J. McGill |
|---|---|
| Phone: | (212) 779-9910 |
| Fax; | (212) 779-9928 |
| Product: | 3TP Workspace |
| Imaging Processing Software for MR Devices | |
| Manufactured by: | 3TP LLC |
| Distributed by: | 3TP LLC |
Indications for Use 1)
The 3TP Workspace is intended for use in conjunction with 3TP's proprietary post processing pharmacokinetic analysis software (FDA 510(k) number: K03150) to provide additional mathematical and/or statistical information specific to a particular region within a 3TP color-coded image. The 3TP Workspace does not change the original 3TP Software algorithm or the image series produced by the 3TP algorithm. The 3TP Workspace supports the analysis and presentation of datasets generated by 3TP Software algorithm and incorporates the following functions: Region of Interest curve (ROI), Pixel of Interest curve (POI), Report Card, Volume Calculation, Statistical Analysis, and 3-D visualization of 3TP data series.
The POI and ROI curve functions provide contrast enhancement data for a specific pixel or region of interest within the MRI image series. Whereas the POI function measures signal intensity enhancement for a specific pixel, the ROI function averages the enhancement in signal intensity for a manually specified In both cases, the 3TP Workspace presents a graph region (several pixels). depicting the percent change in intensity through all time points.
The Report Card function classifies, counts and calculates the percentage of pixels of a given color and intensity in a single or in multiple slices for any manually specified region of interest. The Report Card offers the user the ability to evaluate a subset of the data originally generated by the 3TP algorithm in a numbers based, non-image presentation format. The Report Card assists the user by providing number based data of the contrast kinetics of a specified region identified by the radiologist in order to further aid in his diagnosis.
The Volume Calculation function provides the user to measure the volume of a region in multiple image slices specified by the radiologist.
The Statistical Analysis provides a standardized statistical analysis of the varying populations of color hue and color intensity within a specified region or volume of interest. This function assists the radiologist in determining the degree of
5
heterogeneity or homogeneity of a user specified region in terms of the color-coded pixels that are contained within.
The 3-D Visualization tool provides colored Maximum Intensity Projections (MIP) or other 3D visualization tools that are specific to the 3TP image datasets.
Device Description 2)
3TP Workspace is intended to be used as post processing software designed to receive 3TP specific series and provide additional tools to analyze those 3TP series. 3TP itself, supports the evaluation of dynamic MR data gathered during the injection of a bolus of contrast media. The resulting time course information can be displayed in a variety of formats, including a parametric image overlaid onto source MR images.
Marketing History 3)
The software has not yet been marketed.
Predicate Devices 4)
| GE Advantage Windows
With Functool Option
(K960265)
GE Medical Systems
300 N. Grandview Blvd.
Waukesha, WI 53186 | GE Prostate Spectroscopy
and Imaging Exam (PROSE)
(K011604)
GE Medical Systems
300 N. Grandview Blvd.
Waukesha, WI 53186 | Philips EasyVision
(Quantitative Analysis
Option) (K971965)
Philips Medical Systems
575 East Sunset Way
Issaquah, WA 98027 |
| --------------------------------------------------------------------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------- |
|---|
Similar to each of the named predicate devices the 3TP Workspace provides a post-processing means for analyzing changes in signal intensity of a contrast agent as reflected in MR images. The use of the 3TP Workspace does not result in any additional hazards, compared to the other post-processing software packages (Functool, PROSE and Philips EasyVision) currently being marketed by GE Medical Systems, and Philips Medical Systems. The 3TP Workspace does not include any new indications for use nor does the use of this device result in any new potential hazards.
Performance Testing 5.
The 3TP Workspace will successfully complete integration testing and verification prior to beta validation and the software beta testing will be successfully completed validating the 3TP Workspace prior to market release.